85 related articles for article (PubMed ID: 1814747)
1. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors.
Miao TJ; Wang Z; Sang N
Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747
[TBL] [Abstract][Full Text] [Related]
2. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens.
Agnantis NJ; Constantinidou A; Poulios C; Pintzas A; Kakkanas A; Spandidos DA
Eur J Surg Oncol; 1990 Apr; 16(2):153-60. PubMed ID: 2182341
[TBL] [Abstract][Full Text] [Related]
4. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor].
Wang Z
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
6. [Expression of oncogene ras product p21 protein in the tissues of penis cancer and its surrounding tissues].
Xin J; Wang X; Meng S
Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):310-1. PubMed ID: 11825397
[TBL] [Abstract][Full Text] [Related]
7. [Expression of mutant P53 gene protein product in human bladder carcinoma].
Ye DW
Zhonghua Wai Ke Za Zhi; 1993 Aug; 31(8):484-6. PubMed ID: 8112175
[TBL] [Abstract][Full Text] [Related]
8. [Expression of ras oncogene p21 in relation to prognostic factors of human breast cancer].
Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Ueno Y; Yamashita H; Nomura K; Ichiguchi O
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2271-5. PubMed ID: 1656890
[TBL] [Abstract][Full Text] [Related]
9. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
10. Ha-ras oncogene product in human oral squamous cell carcinoma.
Oku N; Shimada K; Itoh H
Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
[TBL] [Abstract][Full Text] [Related]
11. Expression of ras p21 oncogene product on human bladder tumors.
Moriyama N; Umeda T; Akaza H; Taniguchi J; Kitamura T; Murakami T; Kawabe K; Aso Y
Urol Int; 1989; 44(5):260-3. PubMed ID: 2678672
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.
Clair T; Miller WR; Cho-Chung YS
Cancer Res; 1987 Oct; 47(20):5290-3. PubMed ID: 3308076
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors express ras oncogene: a potential role for diagnosis and treatment.
Blair SL; Al-Refaie WB; Wang-Rodriguez J; Behling C; Ali MW; Moossa AR
Arch Surg; 2005 Jun; 140(6):543-7; discussion 547-8. PubMed ID: 15967901
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
15. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
Gui K
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
[TBL] [Abstract][Full Text] [Related]
16. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
Leng J; Zhang Y; Yao X; Wen K
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
19. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
20. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder.
Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T
Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]